With 0.61 million shares changed hands, the volume of the stock remained heavier than its average volume of 82260.0 shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $9.41 whereas the lowest price it dropped to was $6.79. The 52-week range on SSII shows that it touched its highest point at $22.42 and its lowest point at $2.48 during that stretch. Beta for the stock currently stands at -147.25.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SSII was up-trending over the past week, with a rise of 34.07%, but this was up by 68.33% over a month. Three-month performance surged to 33.68% while six-month performance fell -4.32%. The stock gained 15.21% in the past year, while it has gained 102.45% so far this year.
Float and Shares Shorts:
At present, 193.59 million SSII shares are outstanding with a float of 30.70 million shares on hand for trading. On 2025-09-30, short shares totaled 94246.0, which was 5.0 higher than short shares on 1756425600. In addition to Dr. Sudhir Prem Srivastava M.D. as the firm’s Founder, CEO & Chairman, Dr. Vishwajyoti P. Srivastava M.D. serves as its Chief Executive Officer of APAC & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, SSII reported revenue of $10000305.0 and operating income of $97014.0. The EBITDA in the recently reported quarter was $574199.0 and diluted EPS was $0.0.
